Therapeutic efficacy of fuzheng-huayu tablet based traditional chinese medicine syndrome differentiation on hepatitis-B-caused cirrhosis: a multicenter double-blind randomized controlled trail - Wikidata - awgldk - TriplyDB

Therapeutic efficacy of fuzheng-huayu tablet based traditional chinese medicine syndrome differentiation on hepatitis-B-caused cirrhosis: a multicenter double-blind randomized controlled trail

Therapeutic efficacy of fuzheng-huayu tablet based traditional chinese medicine syndrome differentiation on hepatitis-B-caused cirrhosis: a multicenter double-blind randomized controlled trail

http://www.wikidata.org/entity/Q36711606

about

Anti-fibro-hepatocarcinogenic Chinese herbal medicines: A mechanistic overview Current Status of Herbal Medicines in Chronic Liver Disease Therapy: The Biological Effects, Molecular Targets and Future Prospects Curative Effects of Fuzheng Huayu on Liver Fibrosis and Cirrhosis: A Meta-Analysis Characteristic Analysis from Excessive to Deficient Syndromes in Hepatocarcinoma Underlying miRNA Array Data.Potent natural products and herbal medicines for treating liver fibrosis Actions of Huangqi decoction against rat liver fibrosis: a gene expression profiling analysis.Fuzheng Huayu Recipe Ameliorates Liver Fibrosis by Restoring Balance between Epithelial-to-Mesenchymal Transition and Mesenchymal-to-Epithelial Transition in Hepatic Stellate Cells.Transcriptional Profiling and miRNA-Target Network Analysis Identify Potential Biomarkers for Efficacy Evaluation of Fuzheng-Huayu Formula-Treated Hepatitis B Caused Liver Cirrhosis.Adaption and application of the four phase trials to traditional chinese medicines.Curative Effects of ZHENG-Based Fuzheng-Huayu Tablet on Hepatitis B Caused Cirrhosis Related to CYP1A2 Genetic Polymorphism.Establishment of an Experimental Breast Cancer ZHENG Model and Curative Effect Evaluation of Zuo-Jin Wan.Herbal Medicine Offered as an Initiative Therapeutic Option for the Management of Hepatocellular Carcinoma.Fuzheng Huayu capsule as an adjuvant treatment for HBV-related cirrhosis: A systematic review and meta-analysis.Herbal remedies for liver fibrosis: A review on the mode of action of fifty herbs.

P2860

Q26745650-3AAEA888-9E88-429B-BAA9-E04E98579315 Q26775055-7708D3E7-2088-43C1-91AC-F6D6BE029AA1 Q26798182-23055AC7-8CF5-4F74-8A3E-FCB59577779E Q30725051-3BF45C99-E332-4FF9-AB86-DEB1E53A90B2 Q35494410-E0542415-2472-4CC6-9F0B-74409F431020 Q36384024-2B5FC3F0-E459-447D-B1DC-BE2765FBCE72 Q36529095-9B7486CA-E454-46CA-9907-A4590FB00599 Q37050654-A571B923-E592-42C0-B82A-812D9BEC1663 Q37145020-B4F0E5A3-3569-4C9C-AE31-09A135BD1076 Q37298904-3802EC6F-E559-4FE1-9ACE-59FA204F2B7D Q37380009-F4B22CFB-007D-4510-827E-17D6B4258A15 Q38734645-DF882834-C3D8-4CD3-9C36-3DBE7B46B682 Q47299272-4AEBEBE8-AD59-49BD-A102-7510B3370C27 Q55498732-DE1A88D4-BD4D-4401-BB3D-D96A19ED3E50

P2860

Therapeutic efficacy of fuzheng-huayu tablet based traditional chinese medicine syndrome differentiation on hepatitis-B-caused cirrhosis: a multicenter double-blind randomized controlled trail

http://www.wikidata.org/entity/Q36711606

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Therapeutic efficacy of fuzhen ...... nd randomized controlled trail

@ast

Therapeutic efficacy of fuzhen ...... nd randomized controlled trail

@en

type

label

Therapeutic efficacy of fuzhen ...... nd randomized controlled trail

@ast

Therapeutic efficacy of fuzhen ...... nd randomized controlled trail

@en

prefLabel

Therapeutic efficacy of fuzhen ...... nd randomized controlled trail

@ast

Therapeutic efficacy of fuzhen ...... nd randomized controlled trail

@en

P1433

Q36711606-52619FD0-1A67-430F-890B-A4586EC7BF3B

P1476

Q36711606-51FE27FD-E21E-4813-B4AC-2626BEFFD5A7

P2093

Q36711606-3FA8D471-B287-448B-B296-8DDC6380A30C

Q36711606-4113D4FA-D97D-4518-811C-9EF7E36289AD

Q36711606-47D037E9-70FE-4ABB-B059-19B2191B70B5

Q36711606-4C8F08E0-4C62-453E-88AF-5F2632EA363A

Q36711606-7FAEF5AC-93F4-42A8-BF5E-247CC962537E

Q36711606-891E7548-97D3-462C-9851-5D627BFC89D4

Q36711606-BB7C46D6-D47B-46FE-A138-C3E2C08C9BEB

Q36711606-D4CE7BD6-AC78-4B75-A768-CB6B12521674

Q36711606-DDF6418C-FAE4-49C0-B21A-1C57C4A3D4FA

Q36711606-F4624BD7-8881-4C3E-9B34-431067F50F66

P2860

Q36711606-172DF8EB-075D-49A2-B4B9-3874DF5195EC

Q36711606-26BDC5C0-275C-4F06-9391-D79FC0EAADC5

Q36711606-2B63B5FC-32EC-4447-887A-9329B6532CB9

Q36711606-353ED59C-7A2A-454C-AFA5-138C635E6F01

Q36711606-429C102C-D2D5-4DD4-B9DA-65D5EA0897BA

Q36711606-4EFB6E69-F055-463F-AD2C-4C66168A7AB1

Q36711606-5FF5CEE6-3D13-4163-9278-3DA3463B9C40

Q36711606-73B4639A-C50E-49B8-849B-0433EF18BF5E

Q36711606-7E43BA4B-1B07-42FC-95A9-F5BB8DA50623

Q36711606-84C9F140-F5DC-408C-9087-752AF0B5DC19

P304

Q36711606-A090A44B-0AA1-40E1-B2A4-3470FEBA844C

P31

Q36711606-E0D871B4-7B5D-4D03-B459-1D5BC51185AC

P356

Q36711606-D1DA0A57-6EAE-4BCC-9426-F5DF5E0A25E8

P478

Q36711606-A2615B70-A0AE-49EA-9E84-3553C7CD0664

P577

Q36711606-9BB719ED-BD92-41C8-8668-9C3ADA5533DC

P5875

Q36711606-93938D93-756B-4ACA-8BA3-11A802D7D226

P698

Q36711606-11F5905B-8660-4F3E-981D-AFC4A40229E1

P921

Q36711606-07196F86-B708-4090-8B19-66D42077D328

Q36711606-DF5ECF19-1C5D-4068-8C16-B448FAA218F5

P932

Q36711606-26003824-65D9-4E35-8842-780FBCE1EC51

P356

P1433

Evidence-based Complementary and Alternative Medicine

P1476

Therapeutic efficacy of fuzhen ...... nd randomized controlled trail

@en

P2093

Dong-Ying Xue

http://www.w3.org/2001/XMLSchema#string

Ji-Jia Sun

http://www.w3.org/2001/XMLSchema#string

Lie-Ming Xu

http://www.w3.org/2001/XMLSchema#string

Qing-Shan Zheng

http://www.w3.org/2001/XMLSchema#string

Shi-Bing Su

http://www.w3.org/2001/XMLSchema#string

Wei Zhang

http://www.w3.org/2001/XMLSchema#string

Xiao-Su Wang

http://www.w3.org/2001/XMLSchema#string

Ya-Nan Song

http://www.w3.org/2001/XMLSchema#string

Yi-Yu Lu

http://www.w3.org/2001/XMLSchema#string

Yue-Qiu Gao

http://www.w3.org/2001/XMLSchema#string

P2860

[Investigation on indication of fuzheng huayu capsule against hepatic fibrosis and its non-invasive efficacy evaluation parameters: data analysis of liver biopsy of 50 patients with chronic hepatitis B before and after treatment].

Treatment of depression--newer pharmacotherapies.

Systematic review: The model for end-stage liver disease--should it replace Child-Pugh's classification for assessing prognosis in cirrhosis?

Prognostic models including the Child-Pugh, MELD and Mayo risk scores--where are we and where should we go?

Applications of New Technologies and New Methods in ZHENG Differentiation.

Developing a 'traffic light' test with potential for rational early diagnosis of liver fibrosis and cirrhosis in the community.

Epidemiology and natural history of hepatitis B.

Effects of Fuzheng Huayu 319 recipe on liver fibrosis in chronic hepatitis B.

Hepatitis B: evolving epidemiology and implications for control.

Development of a bayesian forecasting method for warfarin dose individualization.

P304

709305

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2013/709305

http://www.w3.org/2001/XMLSchema#string

P478

2013

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236085048

http://www.w3.org/2001/XMLSchema#string

P698

23533516

http://www.w3.org/2001/XMLSchema#string

P921

liver cirrhosis

multicenter trial

P932

3606729

http://www.w3.org/2001/XMLSchema#string